Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Date of 148 reexam of non-final action

Date of 148 reexam of non-final action

posted on Jan 03, 2008 05:46AM
Notice once again the date reexam of non-final action on the 148 12/21/07. Then the date of Verigy Purchases Microprocessor Patent Portfolio License 12/21/07.
Share
New Message
Please login to post a reply